AAAAAA
Results: 26-50/83
Authors:
KEYSARY A
ITZHAKI A
RUBINSTEIN E
ORON C
KEREN G
Citation: A. Keysary et al., THE IN-VITRO ANTI-RICKETTSIAL ACTIVITY OF MACROLIDES, Journal of antimicrobial chemotherapy, 38(4), 1996, pp. 727-731
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, SAFETY PROFILE OF SPARFLOXACIN IN THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS, Journal of antimicrobial chemotherapy, 37, 1996, pp. 145-160
Authors:
SHLYAKHOV E
BLANCOU J
RUBINSTEIN E
Citation: E. Shlyakhov et al., VACCINES AGAINST ANTHRAX IN ANIMALS, FROM PASTEUR,LOUIS TO DATE, Revue scientifique et technique - Office international des epizooties, 15(3), 1996, pp. 853-862
TOWARD MORE ACCURATE PREDICTIONS OF ENERGY USE AND LIGHT OUTPUT FOR 2BY 4 FT LUMINAIRES - DISCUSSION
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, TOWARD MORE ACCURATE PREDICTIONS OF ENERGY USE AND LIGHT OUTPUT FOR 2BY 4 FT LUMINAIRES - DISCUSSION, Journal of the Illuminating Engineering Society, 25(1), 1996, pp. 67-67
Authors:
RAMON J
DAUTREY S
FARINOTI R
CARBON C
RUBINSTEIN E
Citation: J. Ramon et al., EXCRETION OF CIPROFLOXACIN INTO THE LARGE-BOWEL OF THE RABBIT, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 11-13
Authors:
RUBINSTEIN E
LENAOUR F
LAGAUDRIEREGESBERT C
BILLARD M
CONJEAUD H
BOUCHEIX C
Citation: E. Rubinstein et al., CD9, CD63, CD81, AND CD82 ARE COMPONENTS OF A SURFACE TETRASPAN NETWORK CONNECTED TO HLA-DR AND VLA INTEGRINS, European Journal of Immunology, 26(11), 1996, pp. 2657-2665
Authors:
RUBINSTEIN E
KELLER N
Citation: E. Rubinstein et N. Keller, FUTURE-PROSPECTS AND THERAPEUTIC POTENTIAL OF STREPTOGRAMINS, Drugs, 51, 1996, pp. 38-42
Authors:
APPELBAUM PC
CORMICAN MG
JONES RN
VANNUFFEL P
COCITO C
PECHERE JC
FINCH RG
RUBINSTEIN E
Citation: Pc. Appelbaum et al., NEW STRATEGIES IN INFECTIOUS-DISEASES - RATIONALE FOR THE USE OF NOVEL STREPTOGRAMINS - A SEMINAR-IN-PRINT - QUESTIONS AND ANSWERS, Drugs, 51, 1996, pp. 43-45
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, CEFTAZIDIME MONOTHERAPY VS CEFTRIAXONE TOBRAMYCIN FOR SERIOUS HOSPITAL-ACQUIRED GRAM-NEGATIVE INFECTIONS (VOL 20, PG 1217, 1995), Clinical infectious diseases, 20(6), 1995, pp. 1582-1582
Authors:
RUBINSTEIN E
LODE H
GRASSI C
Citation: E. Rubinstein et al., CEFTAZIDIME MONOTHERAPY VS CEFTRIAXONE TOBRAMYCIN FOR SERIOUS HOSPITAL-ACQUIRED GRAM-NEGATIVE INFECTIONS, Clinical infectious diseases, 20(5), 1995, pp. 1217-1228
Authors:
SEGEV S
RAZ R
RUBINSTEIN E
SHMUELY H
HASSIN D
ROSEN N
PLATAU E
BENASSULI S
PITLIK S
Citation: S. Segev et al., DOUBLE-BLIND RANDOMIZED STUDY OF 1 G VERSUS 2 G INTRAVENOUS CEFTRIAXONE DAILY IN THE THERAPY OF COMMUNITY-ACQUIRED INFECTIONS, European journal of clinical microbiology & infectious diseases, 14(10), 1995, pp. 851-855
Authors:
SHLYAKHOV E
RUBINSTEIN E
Citation: E. Shlyakhov et E. Rubinstein, RAPID BIOASSAY FOR DETECTION OF BACILLUS-ANTHRACIS IN MICE, Journal of veterinary medicine. Series B, 42(6), 1995, pp. 361-368
Authors:
LANG R
BANAI M
LISHNER M
RUBINSTEIN E
Citation: R. Lang et al., BRUCELLOSIS, International journal of antimicrobial agents, 5(4), 1995, pp. 203-208
Authors:
VANDEWIELE B
RUBINSTEIN E
PEACOCK W
MARTIN N
Citation: B. Vandewiele et al., PROPYLENE-GLYCOL TOXICITY CAUSED BY PROLONGED INFUSION OF ETOMIDATE, Journal of neurosurgical anesthesiology, 7(4), 1995, pp. 259-262
Authors:
CORMET E
HUNEAU JF
CARBON C
RUBINSTEIN E
TOME D
Citation: E. Cormet et al., UPTAKE AND TRANSPORT OF SPARFLOXACIN ACROSS CACO-2 CELL MONOLAYERS, The FASEB journal, 9(4), 1995, pp. 690-690
Authors:
SHENKMAN B
DARDIK R
RUBINSTEIN E
SAVION N
MARTINOWITZ U
VARON D
Citation: B. Shenkman et al., PLATELETS MEDIATE BACTERIA DEPOSITION ON SUBENDOTHELIUM - REQUIREMENTFOR PLATELET ACTIVATION, GPIIB IIIA AND GPIB INDEPENDENTLY OF PLASMA VON-WILLEBRAND-FACTOR/, Thrombosis and haemostasis, 73(6), 1995, pp. 1357-1357
Authors:
RUBINSTEIN E
LANG R
Citation: E. Rubinstein et R. Lang, FUNGAL ENDOCARDITIS, European heart journal, 16, 1995, pp. 84-89
Authors:
GAY E
SEKHAR LN
RUBINSTEIN E
WRIGHT DC
SEN C
JANECKA IP
SNYDERMAN CH
Citation: E. Gay et al., CHORDOMAS AND CHONDROSARCOMAS OF THE CRANIAL BASE - RESULTS AND FOLLOW-UP OF 60 PATIENTS, Neurosurgery, 36(5), 1995, pp. 887-896
Authors:
KARETNYI YV
MENDELSON E
SHLYAKHOV E
RUBINSTEIN E
GOLUBEV N
LEVIN R
SANDLER M
SCHREIBER M
RUBINSTEIN U
SHIF I
HANDSHER R
VARSANO N
MODAN B
Citation: Yv. Karetnyi et al., PREVALENCE OF ANTIBODIES AGAINST HEPATITIS-A VIRUS AMONG NEW IMMIGRANTS IN ISRAEL, Journal of medical virology, 46(1), 1995, pp. 61-65
Authors:
RUBINSTEIN E
BOUCHEIX C
WORTHINGTON RE
CARROLL RC
Citation: E. Rubinstein et al., ANTIPLATETLET ANTIBODY INTERACTIONS WITH FC-GAMMA RECEPTOR, Seminars in thrombosis and hemostasis, 21(1), 1995, pp. 10-22
Authors:
RUBINSTEIN E
DAUTREY S
FARINOTI R
STJULIEN L
RAMON J
CARBON C
Citation: E. Rubinstein et al., INTESTINAL ELIMINATION OF SPARFLOXACIN, FLEROXACIN, AND CIPROFLOXACININ RATS, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 99-102
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, WINDS OF CHANGE, Science, 270(5239), 1995, pp. 1099-1099
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, PUNCTUATED EQUILIBRIUM IN SCIENTIFIC PUBLISHING (VOL 268, PG 1415, 1995), Science, 269(5230), 1995, pp. 1501-1501
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, SUCCEEDING GENERATIONS - REPLY, Science, 269(5221), 1995, pp. 146-146
Authors:
RUBINSTEIN E
Citation: E. Rubinstein, PUNCTUATED EQUILIBRIUM IN SCIENTIFIC PUBLISHING, Science, 268(5216), 1995, pp. 1415-1415